• Berberrubine Chloride Regulates Urate Transporters to Allevi

  2026-06-21

  A recent study reveals that berberrubine chloride, a major metabolite of berberine, significantly reduces hyperuricemia in a mouse model by modulating urate transporters and suppressing the JAK2/STAT3 pathway. These findings underscore its translational promise as an anti-hyperuricemia agent and provide mechanistic insight into its renal protective effects.

• Hexetidine (NSC-17764): Mechanistic Precision in Oral Biofil

  2026-06-20

  Explore how Hexetidine (NSC-17764) sets a mechanistic benchmark for oral biofilm disruption and antimicrobial selectivity. This article delivers a deeper dive into its strain-specific action and practical protocol optimization, offering new value beyond standard overviews.

• A-1331852: Redefining BCL-XL Inhibition in Cancer Biology

  2026-06-19

  Explore how A-1331852, a potent BCL-XL inhibitor, advances apoptosis research by enabling precision targeting of anti-apoptotic proteins. This article delivers a nuanced analysis of selective BCL-XL inhibition, integrating breakthrough findings and translational strategy.

• Berbamine Hydrochloride: Applied NF-κB Activity Inhibitor Wo

  2026-06-19

  Berbamine hydrochloride enables precise NF-κB signaling pathway inhibition and ferroptosis modulation in cancer research. This guide details protocol parameters, workflow enhancements, and troubleshooting tips—bridging mechanistic innovations with practical bench execution.

• Small-Molecule Activators of Human ClpP: Mechanisms and Canc

  2026-06-18

  This review highlights recent advances in designing small-molecule activators of human mitochondrial ClpP, focusing on the structural and mechanistic basis for their anticancer activity. The findings clarify how selective ClpP activation disrupts mitochondrial proteostasis, pointing to new metabolic vulnerabilities in tumor cells and informing rational drug development.

• Dihydroethidium: Precision Superoxide Detection in Redox Bio

  2026-06-18

  Dihydroethidium (DHE) enables robust, cell-permeable superoxide quantification, empowering researchers to dissect oxidative stress in live systems. This article translates the latest experimental workflows and troubleshooting insights into actionable guidance for apoptosis and cardiovascular disease research.

• Fasudil (HA-1077) HCl: Optimizing ROCK Inhibition in Cancer

  2026-06-17

  Fasudil (HA-1077) HCl stands out as a uniquely selective ROCK inhibitor, enabling advanced investigation of cell proliferation and migration in cancer and hematological research. Its robust inhibition profile, distinct chemical structure, and proven in vivo efficacy streamline experimental design and troubleshooting for Rho/ROCK pathway studies.

• Protease Inhibitor Cocktail EDTA-Free: Precision in Protein

  2026-06-17

  Safeguard protein integrity during extraction and phosphorylation analysis with the EDTA-free Protease Inhibitor Cocktail from APExBIO. Discover validated workflows, troubleshooting strategies, and the unique benefits of an EDTA-free, DMSO-based formulation for sensitive downstream applications.

• LY2886721: BACE Inhibitor Precision in Alzheimer’s Research

  2026-06-16

  LY2886721 empowers Alzheimer’s disease researchers with nanomolar potency and oral bioavailability, enabling precise modulation of amyloid beta production without compromising synaptic function at optimized doses. This guide unpacks experimental workflows and troubleshooting strategies to unlock its full potential in translational neurodegeneration models.

• IWP-2: Wnt Production Inhibitor for Advanced Cancer Research

  2026-06-16

  IWP-2 empowers targeted disruption of Wnt signaling, enabling precise control in cancer and regenerative medicine assays. This guide details stepwise workflows, troubleshooting strategies, and innovative applications—bridging recent advances in epithelial cell culture with robust cancer model interrogation.

• Berberine Hydrochloride: Advanced Workflows in Metabolic and

  2026-06-15

  Berberine Hydrochloride from APExBIO enables precise metabolic and inflammation studies by leveraging robust AMPK activation and inflammasome modulation. This article delivers actionable protocols, troubleshooting insights, and a synthesis of emerging evidence, optimizing its use for metabolic disease and acute kidney injury models.

• Rottlerin as a Selective PKCδ Inhibitor: Mechanistic Insight

  2026-06-15

  Explore the multifaceted roles of Rottlerin, a potent PKC inhibitor, in modulating cell proliferation and apoptosis. This article delivers advanced mechanistic analysis and practical insights distinct from prior content, offering fresh perspectives for experimental design.

• Decoding Mitochondrial Collapse: Strategic Insights for Tran

  2026-06-14

  This article unpacks the mechanistic role of mitochondrial membrane potential in cell fate, leveraging the latest insights on sodium-induced dysfunction and the strategic deployment of the TMRE mitochondrial membrane potential assay kit for translational researchers. By integrating evidence from recent breakthroughs and practical assay guidance, it offers a roadmap for advancing disease modeling and therapeutic evaluation.

• Parathyroid hormone (1-34) (human): Empowering Advanced Bone

  2026-06-13

  Parathyroid hormone (1-34) (human) unlocks high-fidelity modeling of bone metabolism and kidney function, bridging mechanistic insight with translational impact. Its potent, reproducible activity streamlines workflows for osteoporosis, serum calcium regulation, and organoid innovation.

• 25-Hydroxycholesterol Shapes Immunosuppressive Macrophage Me

  2026-06-12

  Xiao et al. demonstrate that 25-hydroxycholesterol (25HC) accumulation in tumor-associated macrophages drives immunosuppressive polarization by activating a lysosomal AMPK–STAT6 axis. Targeting CH25H, the enzyme for 25HC biosynthesis, reprograms macrophages and enhances anti-tumor immunity, offering a novel metabolic checkpoint for immunotherapy.

453 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page